Highly Enantioselective Hydrogenation of tetra-and tri-Substitutedα,β-Unsaturated Carboxylic Acids with oxa-Spiro Diphosphine Ligands  被引量:4

在线阅读下载全文

作  者:Gen-Qiang Chen Jia-Ming Huang Bi-Jin Lin Chuan Shi Ling-Yu Zhao Bao-De Ma Xiao-Bing Ding Qin Yin Xumu Zhang 

机构地区:[1]Department of Chemistry,Guangdong Provincial Key Laboratory of Catalysis,Southern University of Science and Technology,Shenzhen 518000 [2]Academy for Advanced Interdisciplinary Studies,Southern University of Science and Technology,Shenzhen 518000

出  处:《CCS Chemistry》2020年第6期468-477,共10页中国化学会会刊(英文)

基  金:the Free Exploration Fund from the Shenzhen Science and Technology Innovation Committee(JCYJ20170817105056467);the Youth Fund from National Natural Science Foundation of China(No.21901107);X.Zhang is indebted to Southern University of Science and Technology(start-up fund),Shenzhen Science and Technology Innovation Committee(nos.KQTD20150717103157174 and JSGG20170821140353405);Guangdong Provincial Key Laboratory of Catalysis(No.2020B121201002);National Natural Science Foundation of China(No.21991113);SZDRC Discipline Construction Program for financial support.

摘  要:We herein present the design and synthesis of a structurally unique oxa-spirocyclic diphosphine ligand,termed as O-SDP.The diphosphine ligand O-SDP derived from oxa-spirocyclic diphenols(O-SPINOL)has a relatively larger bite angle compared with that of SDP,and O-SDP has been successfully applied in the ruthenium-catalyzed asymmetric hydrogenation ofα,β-unsaturated carboxylic acids under mild reaction conditions.High yields and enantioselectivities were generally achieved for a wide range of substrates(up to 99%yield and>99%ee),and many of the resulting products are key intermediates of important drugs such as Sacubitril,Artemisinin,and Paroxetine.

关 键 词:asymmetric hydrogenation DIPHOSPHINE O-SDP O-SPINOL 

分 类 号:O62[理学—有机化学]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象